Clinical trial
Tight Glycemic Control With Intensive Insulin Therapy in PICU
NCT00214916 · Greet Van den Berghe, Other · Unknown status
Key facts
| NCT number | NCT00214916 |
|---|---|
| Title | Tight Glycemic Control With Intensive Insulin Therapy in PICU |
| Official title | KULeuven Intensive Insulin Study in Pediatric Intensive Care Patients |
| Lead sponsor | Greet Van den Berghe, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Critical Illness |
| Intervention type | Drug |
| Interventions | intensive insulin therapy (Actrapid IV to normoglycemia), conventional insulin therapy (Actrapid IV only for excessive hyperglycemia) |
| Enrollment | 700 |
| Start date | Oct 1, 2004 |
| Primary completion | Feb 1, 2008 |
| Completion | Jun 1, 2023 |
| First posted | Sep 22, 2005 |
| Last update posted | Mar 10, 2022 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: